IberoAmerican Pharmacogenetics Network Red Iberoamericana de - PowerPoint PPT Presentation

Oct 20, 2022 •40 likes •250 views

IberoAmerican Pharmacogenetics Network Red Iberoamericana de Farmacogentica Enrique Tern MD PhD On behalf of the RIBEF researchers team Jose Mara Chema Cant (+) Mexican pioneer in Genetics Human Genome Project LA Leader TOXICITY

IberoAmerican Pharmacogenetics Network Red Iberoamericana de Farmacogenética Enrique Terán MD PhD On behalf of the RIBEF researchers team
Jose María “Chema” Cantú (+) Mexican pioneer in Genetics Human Genome Project LA Leader
TOXICITY Slow Metabolizers LACK EFFICACY Ultrarapid Metabolizers
Interethnical variability: CYP2D6 gene multiplication (Ultrarapids?) Interethnic distribution of individuals with CYP 2D6 gene duplicated
Adrián LLerena 2016 allerena@unex.es
RIBEF Activities 2006-2014 Activity Number Countries involved Diffusion of information 322 31 Capacitation of Human 101 12 resources Production of Scientific 22 13 information Guidance to Clinical 1 02 implementation Total 446 31
Diffusion activities per year
CEI CEIBA A Con onsor sorcio cio Eur urop opeo eo Ib Iber ero o Amer merican icano o Far armac macog ogen enét ética ica Population Pharmacogenetics among Iberoamerican populations N= 6050
African Admixed Ashkenazi Native Caucasians 6050 Americans Americans Jews Americans Volunteers 1384 1824 96 2571 174 CEIBA Consortium POR CUB 2016 MEX NIC SPA CRI n=426 COL n=98 ECU n=294 n=452 n=713 BRA n=528 PER n=1550 n=133 n=286 URU n=32 CHI n=1081 n=456 ARG
MESTIFAR: Relationship with ancestry (declare/molecular markers) ARG PER MEX MEX PER
IBEROFEN 17IA004 GENES AND METABOLIC PHENOTYPES IN AMERICAN POPULATION Interaction genes-environment on the metabolic phenotype in autochthonous and admixed populations in Iberoamerica
Pasantías =81 HR exchange =86
Training = 343 activities
Publications =51

Recommend

Ron van Schaik Associate Professor Pharmacogenetics Eur Clin Chem / Advisor EMA - PGWG London,

Ron van Schaik Associate Professor Pharmacogenetics Eur Clin Chem / Advisor EMA - PGWG London, Oct 8-9, 2012 Pharmacogenetics Clinical implementation: a 7 year experience Pharmacogenetics Core Laboratory* Dept. Clinical Chemistry Erasmus MC

1.01k views • 35 slides

Privacy in Pharmacogenetics: An End-to-End Case Study of Personalized Warfarin Dosing Presented

Privacy in Pharmacogenetics: An End-to-End Case Study of Personalized Warfarin Dosing Presented By Sharani Sankaran Pharmacogenetics We Introduce an Attack called the Model Inversion Attack Genomic privacy= Extract Patients Genetics from

652 views • 21 slides

Final Results of Project CReAN of the Iberoamerican FORO Sixth Meeting of the Steering Committee

Final Results of Project CReAN of the Iberoamerican FORO Sixth Meeting of the Steering Committee on Competence of Human Resources for the Regulatory Bodies IAEA, Vienna, 18-21 November 2014 Ana M. Larcher, ARN, Argentina alarcher@arn.gob.ar

699 views • 25 slides

Experience with Pharmacogenetics and Clinical Research in Africa Africas genomic diversity, an

Experience with Pharmacogenetics and Clinical Research in Africa Africas genomic diversity, an opportunity for advances in personalised healthcare Collen Masimirembwa (PhD, DPhil) Founder and Chief Scientific Officer African Institute of

417 views • 24 slides

Genomics in Patients with Hispanic ancestry - Pharmacogenetics in Hispanics and Its clinical

EMA Workshop on Pharmacogenomics: from science to clinical care October 8-9, 2012 Genomics in Patients with Hispanic ancestry - Pharmacogenetics in Hispanics and Its clinical implications - Adrin LLerena MD PhD Clinical Research Centre

339 views • 29 slides

CPIC: Clinical Pharmacogenetics Implementation Consortium December, 2011 Dr Howard L. McLeod

CPIC: Clinical Pharmacogenetics Implementation Consortium December, 2011 Dr Howard L. McLeod Eshelman Distinguished Professor and Director Institute for Pharmacogenomics and Individualized Therapy (IPIT) UNC Chapel Hill, NC

407 views • 26 slides

A Statistical Approach to Scanning the Biomedical Literature for Pharmacogenetics Knowledge. DL

A Statistical Approach to Scanning the Biomedical Literature for Pharmacogenetics Knowledge. DL Rubin, CF Thorn, TE Klein, RB Altman. JAMIA Vol 12, No 2, pp121-129. Patrick Herron INLS 279 19 April 2005 A Statistical Approach to Scanning the

244 views • 12 slides

Regulatory perspectives Gordon Duff, St Hilda's College, Oxford, UK Contents 1. Role of MHRA and

Pharmacogenetics and Stratified Medicine Network Conference Wellcome Trust Genome Campus, Cambridge,14 January 2015 Regulatory perspectives Gordon Duff, St Hilda's College, Oxford, UK Contents 1. Role of MHRA and its 3 centres 2. NIBSC and

440 views • 30 slides

Clinical trial design in stratified medicine an example in colorectal cancer Tim Maughan

Clinical trial design in stratified medicine an example in colorectal cancer Tim Maughan Professor of Clinical Oncology University of Oxford Pharmacogenetics and Stratified Medicine Network January 2015 What is the problem? Every

793 views • 32 slides

MRC Stratified Medicine Initiative Jonathan Pearce Medical Research Council, Translational

MRC Stratified Medicine Initiative Jonathan Pearce Medical Research Council, Translational Programme Manager Pharmacogenetics and Stratified Medicine Network Conference : 14 th January 2015 Stratified medicine has the potential to deliver

716 views • 15 slides

1 Network Layer Network Layer Recall: Circuit Switching vs. Packet Interplay between routing

Network Layer Network Layer Chapter 4: Network Layer Mobile network Chapter goals: Global ISP understand principles behind network layer Network Layer services: Home network network layer service models Regional ISP forwarding

550 views • 3 slides

MOL2NET, 2018 , 4, http://sciforum.net/conference/mol2net-04 2 visualizations, it has been widely

MOL2NET, 2018 , 4, http://sciforum.net/conference/mol2net-04 1 MOL2NET, International Conference Series on Multidisciplinary Sciences: Iberoamerican MDPI Workshop on Modelization and Simulation Methods, Valencia, Spain, 2018. Molecular Docking

438 views • 4 slides

5 Network Layer Network Layer Network Layer Network Layer Example: Choosing among multiple ASes

Network Layer Network Layer Network Layer Network Layer Network Layer Comparison of LS and DV algorithms Message complexity Robustness: what happens 1 Introduction 5 Routing algorithms if router malfunctions? LS: with n nodes, E

325 views • 4 slides

7 Network Layer Network Layer Network Layer Network Layer Subnets Classful Address

Network Layer Network Layer Network Layer Network Layer IP Fragmentation & Reassembly IP Fragmentation and Reassembly network links have MTU length ID fragflag offset (max.transfer size) - largest possible link-level frame.

948 views • 5 slides

Simultaneous Scheduling and Control of Multi-Grade Polymerization Reactors Antonio

Simultaneous Scheduling and Control of Multi-Grade Polymerization Reactors Antonio Flores-Tlacuahuac Department of Chemical Engineering Universidad Iberoamericana M exico, DF mailto:antonio.flores@uia.mx June 24, 2008 Outline

1.32k views • 119 slides

Network Coding Network Coding Jie Gao Existing network Existing network Independent data

Network Coding Network Coding Jie Gao Existing network Existing network Independent data stream sharing the same network resources Packets over the Internet Signals in a phone network An analog: cars sharing a highway.

1.01k views • 46 slides

What is network security? Friends and enemies: Alice, Bob, Trudy What is network security?

Network security Network security Foundations: what is security? cryptography Network Security Network Security authentication message integrity key distribution and certification Security in practice: Srinidhi Varadarajan

332 views • 6 slides

1 Creating a network app application transport network data link write programs that

Last time Mobile network Internet overview Global ISP whats a protocol? network edge, core, access network Home network Regional ISP Regional ISP packet-switching versus k t it hi circuit-switching Internet/ISP

524 views • 20 slides

Network Virtualization What is Network Virtualization? Abstraction of the physical network

Network Virtualization What is Network Virtualization? Abstraction of the physical network Support for multiple logical networks running on a common shared physical substrate A container of network services Aspects of the

589 views • 21 slides

4 Network Layer Network Layer Network Layer Network Layer Switching Via Memory Three types of

Network Layer Network Layer Network Layer Network Layer Routing Table Aggregation - > 4 billion Forwarding table Longest prefix matching possible entries Prefix Match Link Interface Destination Address Range Link Interface 11001000

288 views • 3 slides

Network Layer Where we are in the Course Moving on up to the Network Layer! Application

Network Layer Where we are in the Course Moving on up to the Network Layer! Application Transport Network Link Physical CSE 461 University of Washington 2 Topics Network service models Datagrams (packets), virtual circuits

524 views • 28 slides

Network Layer (Routing) Where we are in the Course Moving on up to the Network Layer!

Network Layer (Routing) Where we are in the Course Moving on up to the Network Layer! Application Transport Network Link Physical CSE 461 University of Washington 2 Topics Network service models Datagrams (packets), virtual

757 views • 40 slides

Network Layer Where we are in the Course Moving on up to the Network Layer! Application

840 views • 42 slides

Network Security Network Security Srinidhi Varadarajan Network security Network security

Network Security Network Security Srinidhi Varadarajan Network security Network security Foundations: what is security? cryptography authentication message integrity key distribution and certification Security in practice:

634 views • 36 slides